Meeting
2016 Genitourinary Cancers Symposium
Impact of metformin on outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC): Results from a pooled clinical trials database.
Authors
Lana Hamieh
Dana-Farber Cancer Institute, Boston, MA
Lana Hamieh , Rana R. McKay , Suzanne S Mickey , Xun Lin , Ronit Simantov , Toni K. Choueiri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 531)
DOI
10.1200/jco.2016.34.2_suppl.531
Abstract #
531
Poster Bd #
E14
Abstract Disclosures
Similar Posters
Poster
2015 Genitourinary Cancers Symposium
Impact of statins and survival outcomes in patients with metastatic renal cell carcinoma.
First Author: Rana R. McKay
Poster
2014 Genitourinary Cancers Symposium
Impact of angiotensin system inhibitors (ASI) on outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC): Results from a pooled clinical trials database.
First Author: Rana R. McKay
Poster
2012 ASCO Annual Meeting
Overall survival (OS) in metastatic renal cell carcinoma (mRCC) sequentially treated with different targeted therapies (TTs): Results from a large cohort of patients.
First Author: Giuseppe Procopio
Poster
2023 ASCO Genitourinary Cancers Symposium
The survival outcomes of metastatic non-clear cell renal cell carcinoma in the immunotherapy era: Princess Margaret Cancer Centre (PMCC) experience.
First Author: Esmail Mutahar Al-Ezzi